Finance Leerink Partners Reiterates a Buy Rating on NovoCure Limited (NVCR)August 15, 20250 NovoCure Restricted (NASDAQ:NVCR) is among the greatest medical system shares to purchase in accordance with analysts. Leerink Companions analyst Jonathan Chang…
